v3.22.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash $ 64,737 $ 77,258
Accounts receivable 89 200
Prepaid expenses, deposits, and other current assets 6,176 5,179
Total current assets 71,002 82,637
Fixed assets, net 2,066 1,585
Operating lease right-of-use assets 2,951
Intangible assets, net 7,620 2,029
Other assets 695 725
Total assets 84,334 86,976
Current liabilities:    
Accounts payable 8,235 3,299
Accrued expenses and other current liabilities 3,498 4,259
Operating lease liabilities, current portion 873
Contingent purchase consideration payable 4,887
Total current liabilities 17,493 7,558
Long-term liabilities    
Operating lease liabilities, less current portion 2,108
Total long-term liabilities 2,108
Total liabilities 19,601 7,558
Commitments and contingencies (Note 10)
Stockholders’ Equity:    
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,136,210 at March 31, 2022 and 1,113,919 shares at December 31, 2021 2,486 2,419
Common stock, $0.001 par value. Authorized, 150,000,000 shares; 86,911,646 and 86,367,845 shares outstanding as of March 31, 2022 and December 31, 2021, respectively 87 86
Additional paid-in capital 199,719 198,071
Accumulated deficit (155,849) (138,910)
Treasury stock (512)
Total PAVmed Inc. Stockholders’ Equity 45,931 61,666
Noncontrolling interests 18,802 17,752
Total Stockholders’ Equity 64,733 79,418
Total Liabilities and Stockholders’ Equity $ 84,334 $ 86,976

Source